Autologous CD34+ stem cell therapy (intravitreal)

CD34+ stem cells · University of California, Davis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous CD34+ stem cell therapy (intravitreal), covering 2024-09-23 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa [Phase 1]